Topic: Experts call for 'urgent reform' of side-effect reporting on cancer tr

Experts call for 'urgent reform' of side-effect reporting on cancer trials.

"Dr Witteles and co-author Dr Melinda Telli first became concerned after encountering a number of patients suffering from heart problems following treatment with the cancer drug sunitinib.

The drug has been approved by the US FDA, and is also approved for use on the NHS under its trade name, Sutent, for the treatment of kidney and gastrointestinal cancers, and pancreatic neuroendocrine tumours."

http://info.cancerresearchuk.org/news/a … s?rss=true

Any advice or comments I give are based on personal experiences and knowledge and are my opinions only, they are not to be substituted for professional medical advice. Please seek professional advice from a qualified doctor or medical professional.